PERSANTIN

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Finland, Hong Kong SAR China, Japan, Mexico, Netherlands, Singapore, South Africa, Spain.

Active ingredients

The drug PERSANTIN contains one active pharmaceutical ingredient (API):

1	Dipyridamole UNII 64ALC7F90C - DIPYRIDAMOLE
	Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation.
	Read more about Dipyridamole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Persantin 100 mg Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC07	Dipyridamole	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	596221080000417
ES	Centro de información online de medicamentos de la AEMPS	56981
FI	Lääkealan turvallisuus- ja kehittämiskeskus	105197
HK	Department of Health Drug Office	02701
HR	Agencija za lijekove i medicinske proizvode	HR-H-333318826
JP	医薬品医療機器総合機構	2171010F1409, 2171010F2553, 2171010F3053
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	53988, 86077
NL	Z-Index G-Standaard, PRK	25763
SG	Health Sciences Authority	00206P
ZA	Health Products Regulatory Authority	27/8/0400